DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

ChemoCentryx Q4 EPS $(0.26), Inline, Sales $10M Beat $9.68M Estimate

ChemoCentryx (NASDAQ:CCXI) reported quarterly losses of $(0.26) per share which met the analyst consensus estimate. This is a 23.81 percent decrease over losses of $(0.21) per share from the same period last year. The

Benzinga · 03/10/2020 20:15

ChemoCentryx (NASDAQ:CCXI) reported quarterly losses of $(0.26) per share which met the analyst consensus estimate. This is a 23.81 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $10 million which beat the analyst consensus estimate of $9.68 million by 3.31 percent. This is a 7.16 percent increase over sales of $9.332 million the same period last year.